Нова Зеландия - английски - Medsafe (Medicines Safety Authority)

pharmacia limited company trading as pharmacia - estramustine phosphate 140mg - capsule - 140 mg - active: estramustine phosphate 140mg

Ирландия - английски - HPRA (Health Products Regulatory Authority)

laboratoires grimberg - charcoal, activated; simeticone - capsule - 140 mg/45 milligram(s) - antiflatulents; silicones

Ирландия - английски - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - temozolomide - capsules hard - 140 milligram - other alkylating agents

Малта - английски - Medicines Authority

fair-med healthcare gmbh planckstr. 13, 22765 hamburg, germany - temozolomide - hard capsule - temozolomide 140 mg - antineoplastic agents

Великобритания - английски - myHealthbox

novartis consumer health uk limited - diclofenac sodium - medicated plaster - 140mg - topical products for joint and muskular pain; antiinflammatory preparations, non-steroids for topical use - local symptomatic and short term treatment of pain in acute strains, sprains or bruises of the extremities following blunt trauma, e.g. sports injuries in adolescents from 16 years of age and adults

Ирландия - английски - HPRA (Health Products Regulatory Authority)

allergan pharmaceuticals international limited - bismuth subcitrate potassium, metronidazole, tetracycline hydrochloride - capsule - 140/125/12 milligram - combinations for eradication of helicobacter pylori

Ирландия - английски - HPRA (Health Products Regulatory Authority)

huvepharma nv - paromomycin - oral solution - 140 milligram(s)/millilitre - paromomycin - cattle, pigs - antibiotics

Австралия - английски - Department of Health (Therapeutic Goods Administration)

idt australia ltd - temozolomide, quantity: 140 mg - capsule, hard - excipient ingredients: lactose; sodium starch glycollate type a; silicon dioxide; stearic acid; tartaric acid; gelatin; purified water; sodium lauryl sulfate; indigo carmine; titanium dioxide; shellac; isopropyl alcohol; propylene glycol; iron oxide black; sodium methyl hydroxybenzoate; sodium propyl hydroxybenzoate - temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.e., patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

amgen australia pty ltd - evolocumab, quantity: 140 mg - injection, solution - excipient ingredients: proline; glacial acetic acid; polysorbate 80; sodium hydroxide; water for injections - repatha is indicated as an adjunct to diet and exercise in:,prevention of cardiovascular events,repatha is indicated to reduce the risk of cardiovascular events (myocardial infarction, stroke and coronary revascularisation) in adults with established cardiovascular disease in combination with an optimally dosed statin and/or other lipid-lowering therapies (see clinical trials).,primary hypercholesterolaemia,repatha is indicated in adults with primary hypercholesterolaemia (including heterozygous familial hypercholesterolaemia and non-familial hypercholesterolaemia) to reduce low-density lipoprotein cholesterol (ldl-c): - in combination with a statin or statin with other lipid lowering therapies, or - alone or in combination with other lipid-lowering therapies in patients who are statin-intolerant.,homozygous familial hypercholesterolaemia,repatha is indicated in adults and adolescents aged 12 years and over with homozygous familial hypercholesterolaemia in combination with other lipid lowering therapies.

Австралия - английски - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - colecalciferol, quantity: 140 microgram; alendronate sodium, quantity: 91.37 mg - tablet - excipient ingredients: magnesium stearate; microcrystalline cellulose; colloidal anhydrous silica; mannitol; hypromellose; butylated hydroxytoluene - alendronate plus d 70 mg/70 ?g and alendronate plus d 70 mg/140 ?g tablets are indicated for the treatment of:,osteoporosis in select patients where vitamin d supplementation is recommended.,prior to treatment, osteroporosis must be confirmed by:,the finding of low bone mass of at least 2 standard deviations below the gender specific mean for young adults or by,the presence of osteoporotic fracture